Literature DB >> 6136886

The pupillary effects of opioids.

R B Murray, M W Adler, A D Korczyn.   

Abstract

Morphine's miotic action on the pupil is an easily recognizable and quantifiable effect in man. The neural pathways responsible for regulating pupil size are reasonably well defined. Yet, the mechanisms behind this and related effects of opioids on the eye in humans and laboratory animals have just begun to be explored. In this review, we have attempted to organize the available information on pupillary actions of opioids, emphasizing the dynamic nature of the responses, their species specificity, possible mechanisms of action, and the recently discovered development of tolerance to these actions. Our current knowledge regarding differences among the opioids, the effects of endogenous opioid peptides and the role of the various opiate receptor subtypes in pupillary effects is also summarized.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6136886     DOI: 10.1016/0024-3205(83)90123-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  22 in total

1.  Pharmacodynamics and biophasic drug levels of methionine enkephalin.

Authors:  R J Erb; L M Her; A Abdallah; A K Mitra
Journal:  Pharm Res       Date:  1991-07       Impact factor: 4.200

2.  Pupillometry measures of autonomic nervous system regulation with advancing age in a healthy pediatric cohort.

Authors:  Molly Winston; Amy Zhou; Casey M Rand; Emma C Dunne; Justin J Warner; Lena J Volpe; Brooke A Pigneri; Drew Simon; Thomas Bielawiec; Samantha C Gordon; Sally F Vitez; Aaron Charnay; Stephen Joza; Kristen Kelly; Cia Panicker; Saajidha Rizvydeen; Grace Niewijk; Cara Coleman; Bradley J Scher; David W Reed; Sara M Hockney; Gigi Buniao; Tracey Stewart; Lynne Trojanowski; Cindy Brogadir; Michelle Price; Anna S Kenny; Allison Bradley; Nicholas J Volpe; Debra E Weese-Mayer
Journal:  Clin Auton Res       Date:  2019-09-25       Impact factor: 4.435

Review 3.  Regulatory peptides in the eye.

Authors:  R A Stone; Y Kuwayama; A M Laties
Journal:  Experientia       Date:  1987-07-15

4.  Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone.

Authors:  Oliver Kummer; Felix Hammann; Claudine Moser; Olivier Schaller; Jürgen Drewe; Stephan Krähenbühl
Journal:  Eur J Clin Pharmacol       Date:  2010-09-21       Impact factor: 2.953

5.  Autonomic function in mice lacking alpha5 neuronal nicotinic acetylcholine receptor subunit.

Authors:  Ningshan Wang; Avi Orr-Urtreger; Joab Chapman; Ruth Rabinowitz; Rachel Nachman; Amos D Korczyn
Journal:  J Physiol       Date:  2002-07-15       Impact factor: 5.182

6.  The opiate addiction test: a clinical evaluation of a quick test for physical dependence on opiate drugs.

Authors:  H Ghodse; D R Taylor; J L Greaves; A J Britten; D Lynch
Journal:  Br J Clin Pharmacol       Date:  1995-03       Impact factor: 4.335

7.  Naloxone induces miosis in normal subjects.

Authors:  N Loimer; R Schmid; J Grünberger; L Linzmayer
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 8.  Physical assessment and differential diagnosis of the poisoned patient.

Authors:  K R Olson; P R Pentel; M T Kelley
Journal:  Med Toxicol       Date:  1987 Jan-Feb

9.  Pharmacokinetic-pharmacodynamic modeling of the miotic effects of dihydrocodeine in humans.

Authors:  Helmut Schmidt; Jörn Lötsch
Journal:  Eur J Clin Pharmacol       Date:  2007-09-05       Impact factor: 2.953

10.  Methylnaltrexone: its pharmacological effects alone and effects on morphine in healthy volunteers.

Authors:  James P Zacny; Kristen Wroblewski; Dennis W Coalson
Journal:  Psychopharmacology (Berl)       Date:  2014-05-29       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.